![Earnings call transcript: West Pharmaceutical Q4 2024 beats EPS forecast, stock drops](https://i-invdn-com.investing.com/news/international_newspapers_69x52._150x108_S_1419494241.jpg)
Please try another search
Cathie Wood announced the upcoming closure of the ARK Transparency ETF Despite declines, investors continue to follow Wood’s holdings closely Consider 2 Ark Invest ETFs that offer better value...
Reports Q4 2022 results on Tuesday, July 26, after the market close Revenue Expectation: $52.43 billion; EPS: $2.29 Growth in the cloud computing unit is key for stock performance When Microsoft...
There’s an argument that the post-earnings decline in AT&T stock is an overreaction Subscriber growth was solid, management remains optimistic But two long-running problems with the stock...
In less than six week, oil is down 29%. Since the June 14 peak, it has almost erased all the gains since Russia's invasion of Ukraine on February 24. If anyone continues to think we are not going into...
Micron offered bleak view of semiconductor industry in late June But two major global players provided upbeat results in early July More chipmakers report quarterly profit numbers this week Amid a...
Futures up despite economic concerns Fund managers are now holding the most cash in twenty years Demand worries fail to dent the oil price which moved up On Monday, futures on the Dow, S&P,...
Swings expected in oil and gold prices until Fed decision at least Powell’s take on the economy will also peruse for signs of recession US Q2 GDP on Thursday and Core PCE Inflation on...
Higher mortgage rates historically associated with higher house price growth Buying a real asset with levered, tax-advantage loans is still a good idea This week we will see an acceleration in...